Everything below concerns heptapeptide. We keep the language plain, cite what the science says, and separate well-supported claims from open questions.
Updated 2025-08-09. Numbers and descriptions here follow the published literature rather than marketing material.
Development took place at the Institute of Molecular Genetics of the Russian Academy of Sciences, where a series of short peptides were designed in the 1980s and 1990s. Selank was selected from variants of tuftsin that showed resistance to plasma peptidases. Russian regulatory approval covers it as an anxiolytic agent given intranasally. Outside that market the compound is normally handled as a research chemical rather than a medicine, and no widely recognised international pharmacopoeial monograph exists. The name Selank is a coined trade designation rather than a systematic chemical name.
Enzymatic stability motivates the extra three residues at the carboxyl end. Native tuftsin is cleaved quickly by circulating aminopeptidases and carboxypeptidases, which limits its duration of action and its usefulness as a tool compound. Extending the chain with proline-rich segments is a common design tactic because proline constrains the backbone and slows proteolysis. The same Pro-Gly-Pro motif appears in other Russian-developed peptides of the era. Whether the full seven-residue chain is required for activity, or whether it acts mainly as a prodrug releasing tuftsin, remains unresolved.
Clinical evidence comes mainly from small studies conducted in Russia, several of which were open-label or lacked robust blinding. Reported outcomes include lower anxiety scores, changes in attention measures, and effects on asthenic states following illness. Sample sizes are typically in the tens of participants, and independent replication outside the region is scarce. Reviews published in English generally note the limited methodological quality of the underlying trials. Whether the compound produces clinically meaningful effects under rigorous conditions remains unresolved.
Proposed mechanisms center on modulation of the GABA system, but no single molecular target has been confirmed. Rodent studies report changes in GABA-A receptor expression and in the turnover of serotonin, dopamine, and norepinephrine in several brain regions. Increases in brain-derived neurotrophic factor and its receptor have also been described after repeated administration. These findings come largely from animal models, and the degree to which they describe human neurochemistry remains an open question. The mechanism is best characterized as multi-system and not fully resolved.
Pharmacokinetic data are limited. Like most short peptides, Selank is vulnerable to plasma and tissue peptidases, and its measured half-life in circulation is short, on a minutes scale. The Pro-Gly-Pro tail slows this degradation but does not eliminate it. Intranasal administration is the route described in most reports, with absorption through the nasal mucosa and a hypothesized path into the central nervous system that avoids the blood-brain barrier. Direct measurements of human brain exposure are unavailable, so distribution claims rest on inference from animal work.
| Property | Value | Notes |
|---|---|---|
| Chemical class | Synthetic heptapeptide | Tuftsin analogue with a C-terminal Pro-Gly-Pro tail |
| Amino acid sequence | Thr-Lys-Pro-Arg-Pro-Gly-Pro | Abbreviated TKPRPGP in most catalogues |
| Molecular mass | About 752 Da | Value for the free peptide |
| Solubility | Freely soluble in water | Aqueous solutions are kept cold and used promptly |
| Typical storage | -20 °C, dry, protected from light | Applies to the lyophilised powder before reconstitution |
Pharmacokinetic data are sparse and largely derived from animal work. After intranasal administration the peptide appears in plasma within minutes, and reported half-lives are short, on the order of minutes to tens of minutes. Degradation proceeds through ordinary proteolytic cleavage into constituent amino acids and smaller fragments. Direct evidence that intact Selank reaches brain tissue in meaningful amounts is limited, and the extent of blood-brain barrier penetration is debated. Some authors argue that fragments, not the parent peptide, carry much of the observed activity.
Published clinical work is concentrated in Russian-language journals and generally involves small samples without independent replication. Systematic reviews in English note the shortage of randomised, placebo-controlled trials and the difficulty of verifying methods from translated reports. Outcome measures vary between studies, which complicates pooling of results. Interest in the compound as a cognitive or anxiolytic agent therefore rests on a thinner evidence base than the volume of citations suggests. Replication in well-powered trials with preregistered endpoints would be needed before firm conclusions about efficacy can be drawn.
Identity and purity of selank are established with reversed-phase high-performance liquid chromatography coupled to mass spectrometry. The peptide elutes from C18 columns with acetonitrile gradients in water containing trifluoroacetic acid or formic acid, and detection is usually performed by ultraviolet absorbance near 214 nm. Electrospray ionization in positive mode gives a doubly protonated ion near m/z 377, consistent with a mass of about 752 Da. Amino acid analysis or tandem mass spectrometry of fragment ions confirms the sequence. Because the molecule has no aromatic residues, it lacks a usable 280 nm chromophore, so low-wavelength detection or mass spectrometry is required.
Peptide bonds in selank are susceptible to hydrolysis under strongly acidic or basic conditions, and the terminal proline residues are vulnerable to exopeptidase activity in biological samples. Lyophilized powder stored dry at -20 °C typically remains stable for extended periods, whereas aqueous solutions degrade faster and may lose measurable purity within days to weeks depending on pH, temperature, and microbial load. Repeated freeze-thaw cycles promote aggregation and adsorption to container surfaces. For analytical work, solutions are usually prepared fresh, kept cold, and used within a single working day.
Like CMX-1152, the herbal mixture known as Protandim that supplanted it was marketed by Lifeline as an "anti-aging" supplement that increases the body's antioxidant defenses by upregulating superoxide dismutase, catalase, and glutathione peroxidase. According to the company, the product was initially sold through retail channels such as GNC; however, in 2009, after several consecutive years of multimillion-dollar losses, the company, which by then was doing business under the name LifeVantage, stopped marketing it through retailers and switched to multi-level marketing, selling it instead through a network of commissioned independent distributors. According to LifeVantage, the move from retail to multi-level marketing was prompted by the January 2008 hiring of David W. Brown, (formerly CEO and president of Metabolife) as the company's CEO and president. Beginning in 2005, Protandim was produced under a manufacturing agreement with The Chemins Company of Colorado Springs, Colorado. In July 2008, LifeVantage entered into a new manufacturing agreement with Cornerstone Research & Development to produce Protandim, and with Wasatch Product Development to produce a Protandim-based skin cream (TrueScience). In 2006, biochemist Joe M. McCord joined the LifeVantage board of directors as the company's director of science. McCord, who is listed by the U.S. Securities and Exchange Commission as a LifeVantage insider shareholder, served as a spokesperson for Protandim and was responsible for distributor training and product research.
Naram-Sin was a son of Manishtushu. He was thus a nephew of King Rimush and grandson of Sargon and Tashlultum. Naram-Sin's aunt was the High Priestess Enheduanna. Most recensions of the Sumerian King List show him following Manishtushu but the Ur III version of the king list inverts the order of Rimush and Manishtushu. To be fully correct, rather than Naram-Sin or Naram-Suen "in Old Akkadian, the name in question should rather be reconstructed as Naram-Suyin (more precisely, /narām-tsuyin/) or Naram-Suʾin (/narām-tsuʾin/)".
== Bibliography == Touati, Sylvie (1976). Discrimination en France à l'égard des femmes dans l'emploi [Discrimination against women in employment in France] (in French). Mémoire DES. Boutillier, Sophie; Lestrade, Brigitte (2004). Le travail des femmes: axes d'émancipation [Women's work: paths to empowerment] (in French). Harmattan. Cova, A (1997). Maternité et droits des femmes en France, XIXe et XXe siècles [Motherhood and women's rights in France, 19th and 20th centuries] (in French). Paris: Anthropos. Milewski, Françoise; Périvier, Hélène (2011). Les discriminations entre les femmes et les hommes [Discrimination between women and men] (in French). Les Presses de Sciences Po. Fortino, Sabine (1999). "De la ségrégation sexuelle des postes à la mixité au travail : étude d'un processus" [From gender segregation in the workplace to gender diversity: a study of a process]. Sociologie du Travail (in French). 41 (4): 363–384. Maruani, Margaret (2011). Travail et emploi des femmes [Women's work and employment] (in French). La Découverte. Moreau, Marie-Pierre (2011). Les enseignants et le genre [Teachers and gender] (in French). Presses Universitaires de France.
Dentogingival junction The dentogingival junction consists of three epithelial components: the gingival epithelium, which covers the external gingival surface; the sulcular epithelium, which lines the gingival sulcus; and the junctional epithelium (JE), which forms a specialized epithelial attachment between the gingiva and the tooth surface. The junctional epithelium is of particular importance in assessing clinical attachment level (CAL). In periodontal health, the JE is located at or near the cemento-enamel junction (CEJ). In periodontitis, inflammatory processes lead to apical migration of the JE along the root surface, which represents true loss of periodontal attachment.
An open condition, called "open channel flow", e.g. the ocean, a swimming pool, or the atmosphere. A closed condition, called "closed conduit", e.g. a water line or gas line. Pressure in open conditions usually can be approximated as the pressure in "static" or non-moving conditions (even in the ocean where there are waves and currents), because the motions create only negligible changes in the pressure. Such conditions conform with principles of fluid statics. The pressure at any given point of a non-moving (static) fluid is called the hydrostatic pressure. Closed bodies of fluid are either "static", when the fluid is not moving, or "dynamic", when the fluid can move as in either a pipe or by compressing an air gap in a closed container. The pressure in closed conditions conforms with the principles of fluid dynamics. The concepts of fluid pressure are predominantly attributed to the discoveries of Blaise Pascal and Daniel Bernoulli. Bernoulli's equation can be used in almost any situation to determine the pressure at any point in a fluid. The equation makes some assumptions about the fluid, such as the fluid being ideal and incompressible. An ideal fluid is a fluid in which there is no friction, it is inviscid (zero viscosity). The equation for all points of a system filled with a constant-density fluid is
Sources: en.wikipedia.org
On 7 April, Hikmat al-Hijri dissolved the Supreme Legal Committee in Suwayda, the judge Shadi Fayez Murshid was tasked with forming the Administrative Council of Jabal Bashan. On 11 April, people went to the streets at al-Karama Square to show their support for Hikmat al-Hijri. On 12 April 2026, clashes occurred between the Syrian Armed Forces and the National Guard along Maghdal–Mazraa. The next day, clashes took place between the Syrian Armed Forces and the National Guard along the Tel Hadid–industrial area. On 13 April, clashes between the Syrian Armed Forces and the National Guard took place along the Tel Hadid–industrial area. Also an assassination attempt was made against Anad Makarem, after he threatened the National Guard with a "popular uprising", Makarem was left in critical condition. On 15 April, the rival Druze leader Munir Najib al-Bahri was killed by unknown assailants. On 27 April, it was reported that the car of commander Basel al-Shaer was targeted. On 28 April, it was reported that the home of Rawad Abdul Khaleq, commander of the “Rapid Intervention” battalion in the National Guard, was attacked with gunfire and that the car of commander Farouk al-Naddaf was targeted with a Molotov cocktail.
In a 2023 survey of 14 European newborn screening programs, there was one pan-European research study with 2 pilot trials planned in Germany (NEW_LIVES) and Italy, the others included three initiatives in Italy, three in the Netherlands, two in Spain, one in Belgium, one in England, one in Germany, one in Greece and one in France. Of the 14 initiatives, 11 selected a single NGS approach for their studies: 6 initiatives planned to use only whole genome sequencing (WGS) as a first-tier test for NBS, including one also testing parents using whole exome sequencing (WES) to facilitate filtering variants, 3 initiatives use classical NGS gene panels, 2 initiatives will be using WES and 2 initiatives will use a mixed approach: one comparing WES and Whole genome sequencing (WGS) and one comparing WES, WGS, and classical NGS. gene panels.
=== Vaccine Impact Modelling Consortium === The Vaccine Impact Modelling Consortium (VMIC) consists of mathematical models of diseases to analyze the impact of Gavi's vaccines, mainly in terms of deaths averted and disability-adjusted life year loss prevented, and to help Gavi come up with ways to maximize the impact for a given amount of resources. It consists of several different groups of modellers working independently. In 2026, the VMIC published an analysis on the impact Gavi's vaccination programmes against 14 vaccine-preventable diseases across 117 low- and middle-income families. In terms of lives saved per 1000 vaccinations, HPV (11.24), measles (6.09), HepB (5.00), and malaria (2.78) were found to be the most imapctful. In terms of DALY-loss prevented per 1000 vaccinations, HPV (523.04), measles (411.01), malaria (203.04), and Hib (150.37) were the most impactful. This analysis describes the effect of increasing vaccination on top of an existing level of coverage and disease burden, so vaccinating against a disease that has already achieved herd immunity can appear less impactful.
=== Nanocellulose fibrils === Nanocellulose fibrils (MFC and CNFs) may be isolated from the cellulose fibers using mechanical methods that expose the fibers to high shear forces, delaminating them into nano-fibers. For this purpose, high-pressure homogenizers, grinders or microfluidizers can be used. This process consumes very large amounts of energy and values over 30 MWh/tonne are not uncommon. To address this problem, sometimes enzymatic/mechanical pre-treatments and introduction of charged groups for example through carboxymethylation or TEMPO-mediated oxidation are used. These pre-treatments can decrease energy consumption below 1 MWh/tonne. "Nitro-oxidation" has been developed to prepare carboxycellulose nanofibers directly from raw plant biomass. Owing to fewer processing steps to extract nanocellulose, the nitro-oxidation method has been found to be a cost-effective, less-chemically oriented and efficient method to extract carboxycellulose nanofibers. Functionalized nanofibers obtained using nitro-oxidation have been found to be an excellent substrate to remove heavy metal ion impurities such as lead, cadmium, and uranium. A chemo-mechanical process for production of nanocellulose from cotton linters has been demonstrated with a capacity of 10 kg per day.
Sources: en.wikipedia.org
Selank is a seven-amino-acid peptide built from the tuftsin sequence plus a Pro-Gly-Pro tail. It is produced by chemical synthesis rather than extracted from a natural source. The free peptide is usually supplied as a lyophilised powder or in an aqueous formulation.
Tuftsin is a natural tetrapeptide derived from the Fc portion of immunoglobulin G. Selank retains that tetrapeptide at its N-terminus and adds three residues to improve resistance to enzymatic breakdown. The relationship is structural, and the two molecules are not interchangeable in experimental work.
It holds a product registration in Russia for intranasal use as an anxiolytic. Registrations of that kind are not automatically accepted by regulators elsewhere. In most other countries it is treated as an unapproved substance or a research material.
Reports describe effects on GABA-A receptor expression, monoamine turnover, and neurotrophic factor levels. These are proposed mechanisms drawn mainly from animal models. No single molecular target has been established.